Acute toxicity of concurrent chemoradiation with weekly cisplatin in cervical cancer patients

dc.contributor.authortawin chotitanaprasiten_US
dc.date.accessioned2011-02-21T08:12:34Z
dc.date.available2011-02-21T08:12:34Z
dc.date.created2011-01-24en_US
dc.date.issued2011-01-24en_US
dc.description.abstractBetween January 2009 and August 2009, 19 consecutively previously untreated patients with invasivecervical carcinoma had completed concurrent chemoradiation treatment at Ubonratchathani cancercenter. Clinical stage were IB2 : 2 IIA: 4 IIB : 10 IIIB : 3 . A total of 83 cycles of cisplatin were administeredto the patients ,with a median of 4 cycles (range, 3 - 6 ). Severe hematological occurred in 3 patients (16%)No severe gastrointestinal toxicity occurred, only grade 2 in 1 patients (5 %). The grades of hematologicaland gastrointestinal toxicity were less than other studies. These results may be from lesser numbers ofpatients given cisplatin 6 cycles or more.en_US
dc.identifier.citationJournal of Thai Society of Therapeutic Radiology and Oncology - วารสารมะเร็งวิวัฒน์; Vol.17 No.1 January-June 2011; 6en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/131232
dc.language.isoen_USen_US
dc.publisherJournal of Thai Society of Therapeutic Radiology and Oncology - วารสารมะเร็งวิวัฒน์en_US
dc.rightsThai Society of Therapeutic Radiology and Oncology, Bangkok, Thailanden_US
dc.source.urihttps://thailand.digitaljournals.org/index.php/JTSTRO/issue/archiveen_US
dc.source.urihttps://thailand.digitaljournals.org/index.php/JTSTRO/article/view/4699en_US
dc.titleAcute toxicity of concurrent chemoradiation with weekly cisplatin in cervical cancer patientsen_US
dc.typeOriginal Articleen_US
Files